Imcivree side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Imcivree. Common side effects include abdominal pain upper among females and depression among males.

The phase IV clinical study is created by eHealthMe based on 25 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On May, 28, 2023

25 people who take Imcivree and have side effects are studied.


What is Imcivree?

Imcivree has active ingredients of setmelanotide acetate. eHealthMe is studying from 25 Imcivree users for its effectiveness, alternative drugs and more.

Number of Imcivree reports submitted per year:

Imcivree side effects.

Imcivree side effects by time on the drug*:

< 1 month:

  1. Abdominal discomfort
  2. Abdominal pain
  3. Injection site reaction
  4. Nausea (feeling of having an urge to vomit)

1 - 6 months:

  1. Asthenia (weakness)

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Anger
  2. Cough
  3. Headache (pain in head)
  4. Injection site erythema (redness at injection site)
  5. Injection site hypertrophy (enlargement of an organ or tissue from the increase in size of its cells at injection site)
  6. Injection site swelling
  7. Nausea (feeling of having an urge to vomit)
  8. Sinusitis (inflammation of sinus)
  9. Skin discolouration (change of skin colour)
  10. Staphylococcal infection (an infection with staphylococcus bacteria)

Imcivree side effects by gender *:

female:

  1. Abdominal pain upper
  2. Anger
  3. Asthenia (weakness)
  4. Cough
  5. Injection site erythema (redness at injection site)
  6. Injection site hypertrophy (enlargement of an organ or tissue from the increase in size of its cells at injection site)
  7. Injection site swelling
  8. Sinusitis (inflammation of sinus)
  9. Skin discolouration (change of skin colour)
  10. Abdominal pain

male:

  1. Depression
  2. Abdominal discomfort
  3. Abdominal pain
  4. Headache (pain in head)
  5. Injection site reaction
  6. Staphylococcal infection (an infection with staphylococcus bacteria)

Imcivree side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

  1. Abdominal pain upper
  2. Anger
  3. Asthenia (weakness)
  4. Ephelides (tanned macules found on the skin)
  5. Melanocytic naevus (a type of lesion that contains nevus cells (a type of melanocyte))
  6. Abdominal pain
  7. Abdominal discomfort

10-19:

  1. Nausea (feeling of having an urge to vomit)
  2. Ephelides (tanned macules found on the skin)
  3. Headache (pain in head)
  4. Injection site erythema (redness at injection site)
  5. Injection site reaction
  6. Sinusitis (inflammation of sinus)

20-29:

n/a

30-39:

  1. Depression
  2. Staphylococcal infection (an infection with staphylococcus bacteria)

40-49:

  1. Cough
  2. Skin discolouration (change of skin colour)

50-59:

n/a

60+:

  1. Abdominal pain

* Approximation only. Some reports may have incomplete information.

Do you take Imcivree?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on setmelanotide acetate (the active ingredients of Imcivree) and Imcivree (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Imcivree:

All Imcivree side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: